Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$15.15
-0.23-1.50%
At close: Jul 24, 5:00 PM EST
$15.41
0.261.72%
After Hours: Jul 24, 9:28 AM EST
Q32 Bio Inc Analyst Ratings
QTTBNASDAQ
Consensus Rating1
Outperform
Highest Price Target1
$95.00
Lowest Price Target1
$3.00
Consensus Price Target1
$29.56
Q32 Bio Analyst Ratings and Price Targets | NASDAQ:QTTB | Benzinga
Q32 Bio Inc has a consensus price target of $29.56 based on the ratings of 11 analysts. The high is $95 issued by Wells Fargo on September 11, 2024. The low is $3 issued by BMO Capital on February 11, 2025. The 3 most-recent analyst ratings were released by Wells Fargo, Oppenheimer, and Mizuho on July 13, 2026, July 13, 2026, and May 22, 2026, respectively. With an average price target of $40 between Wells Fargo, Oppenheimer, and Mizuho, there's an implied 159.57% upside for Q32 Bio Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Wells Fargo
Oppenheimer
Mizuho
HC Wainwright & Co.
BMO Capital
1calculated from analyst ratings
Analyst Ratings for Q32 Bio
FAQ
What is the target price for Q32 Bio (QTTB) stock?
The latest price target for Q32 Bio (NASDAQ:QTTB) was reported by Wells Fargo on July 13, 2026. The analyst firm set a price target for $66.00 expecting QTTB to rise to within 12 months (a possible 328.29% upside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Q32 Bio (QTTB)?
The latest analyst rating for Q32 Bio (NASDAQ:QTTB) was provided by Wells Fargo, and Q32 Bio upgraded their overweight rating.
When was the last upgrade for Q32 Bio (QTTB)?
The last upgrade for Q32 Bio Inc happened on July 13, 2026 when Wells Fargo raised their price target to $66. Wells Fargo previously had an equal-weight for Q32 Bio Inc.
When was the last downgrade for Q32 Bio (QTTB)?
The last downgrade for Q32 Bio Inc happened on February 11, 2025 when BMO Capital changed their price target from $22 to $3 for Q32 Bio Inc.
When is the next analyst rating going to be posted or updated for Q32 Bio (QTTB)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Q32 Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Q32 Bio was filed on July 13, 2026 so you should expect the next rating to be made available sometime around July 13, 2027.
Is the Analyst Rating Q32 Bio (QTTB) correct?
While ratings are subjective and will change, the latest Q32 Bio (QTTB) rating was a upgraded with a price target of $0.00 to $66.00. The current price Q32 Bio (QTTB) is trading at is $15.41, which is within the analyst’s predicted range.
